AzTrials
AzTrials

Snac WristNCT07335783

Lunocapitate Fusion in Snac Wrist

A study testing Results of lunocapitate fusion in mangement of scaphoid non union Advanced collapse (SNAC wrist) and Lunocapitate fusion in snac wrist in people with Snac Wrist, run by Assiut University.

Not yet recruiting

Opening soon. The study is approved but enrolment has not started yet. Sites may already take enquiries.

Sites and contacts
Official record
Search all trials

Trial summary

Scaphoid fractures are common, accounting for approximately 60-70% of all carpal bone fractures. StatPearls. Scaphoid Wrist Fracture. (2024). (A significant challenge is the high rate of missed or delayed diagnosis, which occurs in up to 30% of cases initially, often due to subtle radiographic findings). Read more about this study

Who is it for?
Ages 18 to 60 years
Conditions the study is for
Snac Wrist
What is being tested?
Results of lunocapitate fusion in mangement of scaphoid non union Advanced collapse (SNAC wrist) and Lunocapitate fusion in snac wrist
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
35 participants
Where
No sites listed yet
Study dates
1 Jan 2026to 10 Mar 2029
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 60 years
  • All sexes
  • No healthy volunteers
  • Adult

Who may be able to join

  • 1- Age 18-60 years 2- symptomatic SNAC wrist failed conservative management.

Who cannot join

  • 1- total wrist Arthritis 2-systemic arthropathy 3-Infected wrist

Trial locations and contacts

No sites are listed yet. Contact the study team or a site near you to ask about taking part.

Ahmed Hany Ahmed contact

00201151469790

ahani3964@gmail.com

About this study

Official title: Results of Lunocapitate Fusion in Mangement of Scaphoid Non Union Advanced Collapse (SNAC Wrist)

Scaphoid fractures are common, accounting for approximately 60-70% of all carpal bone fractures. StatPearls. Scaphoid Wrist Fracture. (2024). (A significant challenge is the high rate of missed or delayed diagnosis, which occurs in up to 30% of cases initially, often due to subtle radiographic findings). [Orthobullets - Acute Scaphoid Fractures] This is critical because 10-20% of acute scaphoid fractures are prone to nonunion even with appropriate treatment,[ResearhGate - Scaphoid Non-Union]. a risk that rises dramatically to over 80-90% if the fracture is completely untreated or missed.ResearchGate Nonunion can lead to scaphoid nonunion advanced collapse (SNAC) is a progressive and debilitating wrist disorder that arises from an untreated scaphoid fracture, leading to characteristic patterns of osteoarthritis. Surgical intervention is often required to alleviate pain and improve function.National Library Of Medicine Treatment strategies vary based on fracture timing and union status. For acute, nondisplaced fractures, non-surgical management with cast immobilization for 8-12 weeks is the standard initial approach, For displaced acute fractures or cases of established nonunion, surgical intervention is mandatory. Options include open reduction and internal fixation (ORIF) with a compression screw, often with bone grafting. In advanced stages where arthritis has developed (SNAC wrist), salvage procedures like proximal row carpectomy or limited carpal fusions are required. [Orthobullets - Scaphoid Fracture Among the available salvage procedures, lunocapitate (LC) fusion with scaphoid excision presents a compelling surgical option. This technique aims to reduce pain by eliminating the arthritic joint surfaces and stabilizing the midcarpal joint. The theoretical advantages of LC fusion include a simplified biomechanicalconstruct with fewer fusion surfaces, which may potentially lead to a higher rate of arthrodesis, and preservation of a functional range of motion. However, comprehensive prospective studies detailing the outcomes, union rates, and complication profile of this specific procedure are still relatively scarce in the literature. ResearchGate - Lunate-capitate arthrodesis (2024)]. This study is designed to prospectively evaluate the efficacy and safety of lunocapitate fusion as a primary surgical treatment for SNAC wrist. The rationale is to provide robust clinical data that can solidify the role of LC fusion in the management algorithm of this condition.

Lunocapitate (LC) fusion has emerged as a promising salvage technique. By reducing the number of fusion sites compared to other procedures, it aims to achieve a higher union rate, reduce operative time, and better preserve wrist motion. However,comprehensive prospective data on its outcomes are still needed. This study will prospectively evaluate the efficacy and safety of lunocapitate fusion as a primary surgical treatment for SNAC wrist.

Conditions
Snac Wrist
Being tested
Results of lunocapitate fusion in mangement of scaphoid non union Advanced collapse (SNAC wrist), Lunocapitate fusion in snac wrist

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Results of lunocapitate fusion in mangement of scaphoid non union Advanced collapse (SNAC wrist)Procedure or surgery

    Lunocapitate fusion in snac wrist

  • Lunocapitate fusion in snac wristProcedure or surgery

    Lunocapitate (LC) fusion has emerged as a promising salvage technique. By reducing the number of fusion sites compared to other procedures, it aims to achieve a higher union rate, reduce operative time, and better preserve wrist motion. However,comprehensive prospective data on its outcomes are still needed. This study will prospectively evaluate the efficacy and safety of lunocapitate fusion as a primary surgical treatment for SNAC wrist.

Study groups in NCT07335783
Study groupRoleWhat they receive
Lunocapitate fusionExperimentalNot described
Receives: Procedure: Results of lunocapitate fusion in mangement of scaphoid non union Advanced collapse (SNAC wrist); Procedure: Lunocapitate fusion in snac wrist

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. DASH SCORE

    Measured: 12 month

  2. Functional outcome measured by the DASH score at 12 months post-operation

    Measured: 12 month

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted13 Jan 2026
  2. Study start1 Jan 2026 (estimated)
  3. Primary completion30 Dec 2028 (estimated)
  4. Study completion10 Mar 2029 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrolment
35 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07335783
Sponsor's protocol ID
Snac wrist lunocapitate fusion
Status last verified
Dec 2025
First submitted
31 Dec 2025
Last updated
13 Jan 2026
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided

Questions about this trial

What is this clinical trial studying?

A study testing Results of lunocapitate fusion in mangement of scaphoid non union Advanced collapse (SNAC wrist) and Lunocapitate fusion in snac wrist in people with Snac Wrist, run by Assiut University.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: opening soon, as of the sponsor's last update on 13 Jan 2026. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Ahmed Hany Ahmed (00201151469790, ahani3964@gmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

DASH SCORE (time frame: 12 month). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 13 Jan 2026; AzTrials last refreshed its copy on 6 Nov 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in